Reduced Risk Across Multiple Cardiometabolic Risk Factors With OLZ/SAM Compared With Olanzapine: Results From a 24-Week Phase 3 Study
- Resource Type
- Abstract
- Source
- In
Biological Psychiatry 1 May 2021 89(9) Supplement:S339-S339 - Subject
- Language
- ISSN
- 0006-3223